Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCL) Current Deferred Revenue (2016 - 2019)

Historic Current Deferred Revenue for Chs (CHSCL) over the last 10 years, with Q3 2019 value amounting to $336.6 million.

  • Chs' Current Deferred Revenue fell 1770.84% to $336.6 million in Q3 2019 from the same period last year, while for Aug 2019 it was $336.6 million, marking a year-over-year decrease of 1770.84%. This contributed to the annual value of $336.6 million for FY2019, which is 1770.84% down from last year.
  • Per Chs' latest filing, its Current Deferred Revenue stood at $336.6 million for Q3 2019, which was down 1770.84% from $490.2 million recorded in Q2 2019.
  • Chs' Current Deferred Revenue's 5-year high stood at $1.2 billion during Q1 2015, with a 5-year trough of $325.8 million in Q4 2018.
  • Over the past 5 years, Chs' median Current Deferred Revenue value was $423.8 million (recorded in 2017), while the average stood at $552.3 million.
  • As far as peak fluctuations go, Chs' Current Deferred Revenue plummeted by 4204.24% in 2016, and later surged by 3156.1% in 2019.
  • Chs' Current Deferred Revenue (Quarter) stood at $660.3 million in 2015, then decreased by 17.7% to $543.4 million in 2016, then decreased by 23.9% to $413.5 million in 2017, then decreased by 21.21% to $325.8 million in 2018, then grew by 3.32% to $336.6 million in 2019.
  • Its Current Deferred Revenue was $336.6 million in Q3 2019, compared to $490.2 million in Q2 2019 and $735.9 million in Q1 2019.